Benefits

• Dual-action formulation: Combines Linagliptin, a DPP-4 inhibitor, with Metformin Hydrochloride, a biguanide, to enhance glycemic control in type 2 diabetes patients.

• Mechanism of action: Linagliptin increases insulin secretion and decreases glucagon release in a glucose-dependent manner, while Metformin reduces hepatic glucose production and improves insulin sensitivity.

• Convenient dosing: Typically administered twice daily with meals to minimize gastrointestinal side effects.

• Affordable pricing: Available at approximately ৳14.00 per tablet, making it a cost-effective option for diabetes management in Bangladesh.

• Trusted manufacturer: Produced by ACME Laboratories Ltd., a reputable pharmaceutical company in Bangladesh.